But, the ultrasound method did catch a small volume of clinically significant prostate cancers that the MRI scans ultimately missed. The researchers conclude mpUSS can be used as an effective ...

A transrectal ultrasound (TRUS) of the prostate may also be called a prostate sonogram or endorectal ultrasound. A doctor usually performs a TRUS to help diagnose prostate cancer or detect ...

MRI-guided ultrasound A newer method which could hold great potential for treatment is MRI-guided transurethral ablation, or TULSA. This method is minimally invasive and is based on the accurate ...

Treatment time averaged 51 minutes. Prostate volume in the study group decreased on average from 39 cubic centimeters pre-treatment to 3.8 cubic centimeters a year after treatment.

The median PSA level decreased from 6.3 ng/mL to a nadir of 0.26 ng/mL, durable to 0.63 ng/mL at 5 years. At 1 year, the median prostate volume decreased 92% from 37.3 to 2.8 mL.

Patients with prostate cancer demonstrated reduced tumor volume and PSA levels, a key marker of prostate cancer progression, and experienced improved urinary function and maintained sexual function ...

Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound ...

A targeted molecular-imaging method under development at Rochester Institute of Technology could help detect early stages of prostate cancer and improve image-directed biopsies. RIT professor Hans ...

A safer and less invasive treatment option for prostate cancer could soon be on the table, with a novel MRI-guided ultrasound technique eliminating significant cancers in 80 percent of subjects in ...

Precisely delivered ultrasound could be an effective treatment for prostate cancer, with high-frequency sound waves heating and killing off cancer cells, a new study says.

Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study. The Lancet Oncology, 2022; 23 (3): 428 ...